| __timestamp | ADMA Biologics, Inc. | Novavax, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 5915545 | 30659000 |
| Thursday, January 1, 2015 | 7177633 | 36250000 |
| Friday, January 1, 2016 | 10661037 | 15353000 |
| Sunday, January 1, 2017 | 22760560 | 31176000 |
| Monday, January 1, 2018 | 16985290 | 34288000 |
| Tuesday, January 1, 2019 | 29349083 | 18662000 |
| Wednesday, January 1, 2020 | 42219783 | 475598000 |
| Friday, January 1, 2021 | 80942625 | 1146290000 |
| Saturday, January 1, 2022 | 154079692 | 1598951000 |
| Sunday, January 1, 2023 | 258214999 | 556382000 |
Infusing magic into the data realm
In the ever-evolving landscape of biotechnology, revenue growth is a key indicator of a company's success. Over the past decade, ADMA Biologics, Inc. and Novavax, Inc. have been at the forefront of this dynamic industry. From 2014 to 2023, Novavax's revenue surged by an impressive 5,100%, peaking in 2022 with a staggering 1.6 billion dollars. This growth was largely driven by their innovative vaccine developments. Meanwhile, ADMA Biologics, Inc. experienced a remarkable 4,300% increase in revenue, reaching its highest point in 2023 with 258 million dollars, thanks to its advancements in immunoglobulin therapies. Despite Novavax's dominance, ADMA's consistent growth highlights its potential in the biopharmaceutical sector. As we look to the future, these companies continue to shape the biotech landscape, offering promising solutions to global health challenges.
Revenue Insights: Novartis AG and Novavax, Inc. Performance Compared
Revenue Showdown: Bristol-Myers Squibb Company vs ADMA Biologics, Inc.
Breaking Down Revenue Trends: Gilead Sciences, Inc. vs ADMA Biologics, Inc.
Revenue Insights: Takeda Pharmaceutical Company Limited and ADMA Biologics, Inc. Performance Compared
Breaking Down Revenue Trends: Teva Pharmaceutical Industries Limited vs ADMA Biologics, Inc.
Telix Pharmaceuticals Limited vs ADMA Biologics, Inc.: Examining Key Revenue Metrics
Annual Revenue Comparison: Alkermes plc vs ADMA Biologics, Inc.
Breaking Down Revenue Trends: ADMA Biologics, Inc. vs Mesoblast Limited
ADMA Biologics, Inc. and Amphastar Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
ADMA Biologics, Inc. and Xencor, Inc.: A Comprehensive Revenue Analysis
Revenue Insights: Dynavax Technologies Corporation and Novavax, Inc. Performance Compared
Who Generates More Revenue? Xencor, Inc. or Novavax, Inc.